Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1978-07-31
1980-01-22
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
041850963
ABSTRACT:
The novel derivatives of pepstatin have the general formula (I) below in which X, Y and Z, are identical or different, and each represent an amino-acid selected from arginine, glutamic acid, aspartic acid, lysine, histidine and valine, the carboxyl function of the terminal amino-acid being esterifiable. The indices a, b and c are each equal to zero or 1, the sum a+b+c being equal to 1, 2 or 3. The invention also includes the water soluble salts and their preparation, and the compositions containing them. ##STR1## These novel products are particularly useful in the diagnosis and treatment of arterial hypertension due to the action of renine.
REFERENCES:
patent: 3840516 (1974-10-01), Umezawa et al.
patent: 3867364 (1975-02-01), Umezawa et al.
patent: 3869347 (1975-03-01), Umezawa et al.
patent: 3878185 (1975-04-01), Murao et al.
Castro Bertrand
Corvol Pierre
Evin Genevieve
Menard Joel
Agence Nationale de Valorisation de la Recherche (ANVAR)
Phillips Delbert R.
LandOfFree
Novel derivatives of pepstatin, their preparation and compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel derivatives of pepstatin, their preparation and compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel derivatives of pepstatin, their preparation and compositio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-334501